EUVIMEDEUVIMED entdecken
Crossref

The IARC Monographs Program – sowing public confusion, controversy, and criticism: a commentary

David B. Fischer

Journal of Toxicology and Regulatory Policy · 2025

DOI: 10.69982/jtrp-25-0003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Toxicology and Regulatory Policy, 2025. Verfasst von David B. Fischer. Gefördert von: Center for Truth in Science.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article focuses on the Monographs Program, established to address the growing need for cancer classifications of chemicals and other agents. Part I provides an overview of the Program, its global impact, and how International Agency for Research on Cancer’s (IARC) cancer classifications are relied on by U.S. regulatory agencies. Part II discusses two controversial cancer classification decisions involving glyphosate and aspartame, both of which serve to showcase the Monographs Program’s persistent and controversial decision-making process. Indeed, the Program’s cancer classifications continue to roil U.S. federal agencies.

Förderung

  • Center for Truth in Science

Zitieren

APA

Fischer, D. B. (2025). The IARC Monographs Program – sowing public confusion, controversy, and criticism: a commentary. Journal of Toxicology and Regulatory Policy. https://doi.org/10.69982/jtrp-25-0003

Vancouver

Fischer DB. The IARC Monographs Program – sowing public confusion, controversy, and criticism: a commentary. Journal of Toxicology and Regulatory Policy. 2025. doi:10.69982/jtrp-25-0003

BibTeX
@article{Fischer2025,
  author = {Fischer, David B.},
  title = {The IARC Monographs Program – sowing public confusion, controversy, and criticism: a commentary},
  journal = {Journal of Toxicology and Regulatory Policy},
  year = {2025},
  doi = {10.69982/jtrp-25-0003}
}
Kostenlos starten →